Breast cancer drug

The FDA announced another drug shortage today, and it affects more than 200,000 women recently diagnosed with breast cancer and MORE :-/

Subscribe to my personal library and access my articles such as this one and more. Besides, nobody else will research it and write it up for you! Which is why you should subscribe and make your request ;-)

For a glimpse at my work, click the title above (Breast cancer drug)...you can read my entire article about the shortage of a breast cancer drug there.

Down to the bone

Since the U.S. Food & Drug Administration's (FDA) announcement on November 19, 2010, there's a drug on the market called, "Xgeva" (denosumab), which is prescribed for the treatment of skeletal-related events (SREs) in patients with cancer that has metastasized and damaged bone tissue. Skeletal-related events include bone fractures caused by cancer and bone pain that requires radiation. Xgeva is not approved for patients with multiple myeloma or other cancers of the blood.

Let me know just how much more information you would like to have about this drug ;-)

What if you had no blood left?

There is a medical condition called, "Myelofibrosis," that interrupts the production of red blood cells. Since your blood cells are produced within your bones, in what is referred to as "Bone Marrow," what do you think would happen if your bone marrow was replaced with scar tissue? Of course the answer to that is bad news. Does it affect you or your loved ones? Maybe. So, I published an article about it and you can read alllllllll about it by subscribing to my work using the gold button on the right side of this page (SUBSCRIBE).

See you there!